FFC
LABU icon

First Financial Corp’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

First Financial Corp’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15
Closed -$2.49K – 300
2026
Q1 		$2.49K Hold
15
– – ﹤0.01% 291
2025
Q4 		$2.39K Hold
15
– – ﹤0.01% 295
2025
Q3 		$1.4K Hold
15
– – ﹤0.01% 309
2025
Q2 		$854 Hold
15
– – ﹤0.01% 312
2025
Q1 		$915 Hold
15
– – ﹤0.01% 336
2024
Q4 		$1.35K Hold
15
– – ﹤0.01% 370
2024
Q3 		$1.93K Buy
+15
New +$1.96K ﹤0.01% 409

Other funds holding LABU

SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
HHGA
Halbert Hargrove Global Advisors Long Beach, California $2.31B AUM 21.64% 1-Year Est. Return
RQS
Ramsey Quantitative Systems Louisville, Kentucky $112M AUM 16.38% 1-Year Est. Return
PS
PayPay Securities Tokyo, Japan $4.1M AUM 0.16% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

First Financial Corp's LABU Position: Q2 2026 in Review

First Financial Corp sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2026, closing a stake of 15 shares — an estimated $2.49K sold.

First Financial Corp first reported a position in LABU in Q3 2024 and held it in 7 quarters. The position peaked at $2.49K in Q1 2026. 6 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • First Financial Corp reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2026 after selling out during the quarter.
  • First Financial Corp sold 15 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $2.49K.
  • First Financial Corp first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2024 and held it in 7 quarters.
  • First Financial Corp's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $2.49K in Q1 2026.
  • 6 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on First Financial Corp's 13F filing for Q2 2026, filed 7 Jul 2026.